Navigating the Landscape of Female Cancers: Recent Discoveries and Treatment Trends

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".

Deadline for manuscript submissions: 31 May 2025 | Viewed by 47

Special Issue Editors


E-Mail Website
Guest Editor
Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy
Interests: breast cancer; clinical research; translational research; clinical trials; gynecological cancers
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
UOC Oncologia A, Azienda Ospedaliero-Universitaria Policlinico Umberto I, Roma, Italy
Interests: breast cancer; gynecological cancers; ovarian cancer; cervical cancer; endometrial cancer

Special Issue Information

Dear Colleagues,

We are pleased to invite you to contribute to a Special Issue focused on the latest innovations in the field of female malignancies. Female cancers, encompassing breast, ovarian, cervical, and uterine tumors, among others, present significant challenges in healthcare worldwide. However, significant advancements have been made in the diagnosis and treatment of these diseases over the last few decades.

This Special Issue aims to shed light on recent discoveries and treatment trends in female cancers, providing a comprehensive overview of this topic. By exploring emerging research and clinical practices, we aspire to enhance our current understanding of these diseases.

The subject aligns closely with the scope of Cancers, which prioritizes contributions advancing knowledge in oncology, health, and medical research.

In this Special Issue, we welcome original research articles and reviews addressing various aspects of female cancer. Potential topics for submissions include, but are not limited to, the following:

  • Molecular mechanisms underlying the development and progression of female cancer;
  • Novel diagnostic approaches and biomarkers for early detection;
  • Advances in surgical techniques and minimally invasive interventions;
  • Targeted therapies and immunotherapies for different subtypes of female cancer;
  • Multidisciplinary approaches to comprehensive cancer care;
  • Psychosocial support and quality of life interventions for patients and survivors.

We look forward to receiving your contributions.

Dr. Federica Martorana
Dr. Giacomo Barchiesi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • female malignancies
  • breast cancer
  • gynecological cancer
  • ovarian cancer
  • endometrial cancer
  • cervical cancer

Published Papers

This special issue is now open for submission.
Back to TopTop